Danaher (DHR) PT Raised to $290 at Jefferies After Raising CV19 PCR Testing Guidance
Tweet Send to a Friend
Jefferies analyst Brandon Couillard raised the price target on Danaher (NYSE: DHR) to $290.00 (from $270.00) after the company reported ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
